XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Private Placement
Common Stock
Common Stock
Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Dec. 31, 2020 $ 236,492   $ 913   $ 1,628,070   $ 257 $ (1,392,748)
Balance (in shares) at Dec. 31, 2020     91,310          
Conversion benefit included in Convertible Notes issued 230       230      
Issuance of common stock under Employee Stock Purchase Plan 2,139   $ 2   2,137      
Issuance of common stock under Employee Stock Purchase Plan (in shares)     175          
Issuance of common stock under equity incentive plan 4,926   $ 5   4,921      
Issuance of common stock under equity incentive plan (in shares)     476          
Issuance of common stock on exercise of warrants     $ 2   (2)      
Issuance of common stock on exercise of warrants (in shares)     195          
Issuance of common stock on conversion of Convertible Notes 7,878   $ 98   7,780      
Issuance of common stock on conversion of notes (in shares)     9,849          
Stock-based compensation expense 46,851       46,851      
Net loss (220,683)             (220,683)
Net unrealized gain (loss) on short-term investments (263)           (263)  
Comprehensive loss (220,946)              
Balance at Dec. 31, 2021 77,570   $ 1,020   1,689,987   (6) (1,613,431)
Balance (in shares) at Dec. 31, 2021     102,005          
Issuance of common stock under Employee Stock Purchase Plan 1,444   $ 4   1,440      
Issuance of common stock under Employee Stock Purchase Plan (in shares)     407          
Issuance of common stock under equity incentive plan (1,530)   $ 6   (1,536)      
Issuance of common stock under equity incentive plan (in shares)     614          
Issuance of common stock in a private placement   $ 75,145   $ 161   $ 74,984    
Issuance of common stock in a private placement (in shares)       16,129        
Stock-based compensation expense 42,980       42,980      
Net loss (182,024)             (182,024)
Net unrealized gain (loss) on short-term investments (13)           (13)  
Comprehensive loss (182,037)              
Balance at Dec. 31, 2022 $ 13,572   $ 1,191   $ 1,807,855   $ (19) $ (1,795,455)
Balance (in shares) at Dec. 31, 2022     119,155